Report Detail
COVID-19 Impact on Global Live Attenuated Vaccine, Market Insights and Forecast to 2026
- RnM4074219 |
- 23 June, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Live Attenuated Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Live Attenuated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Live Attenuated Vaccine market is segmented into
Children
Adult
Segment by Application, the Live Attenuated Vaccine market is segmented into
Hospital
Medical Center
Others
Regional and Country-level Analysis
The Live Attenuated Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Live Attenuated Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Live Attenuated Vaccine Market Share Analysis
Live Attenuated Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Live Attenuated Vaccine business, the date to enter into the Live Attenuated Vaccine market, Live Attenuated Vaccine product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma (Japan)
CSL Limited (Australia)
Emergent BioSolutions (U.S.)
GlaxoSmithKline (U.K.)
Johnson & Johnson (U.S.)
MedImmune (U.S.)
Merck & Co (U.S.)
Pfizer (U.S.)
Sanofi Pasteur (France)
Serum Institute of India Pvt (India)
1 Study Coverage
- 1.1 Live Attenuated Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Live Attenuated Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Live Attenuated Vaccine Market Size Growth Rate by Type
- 1.4.2 Children
- 1.4.3 Adult
- 1.5 Market by Application
- 1.5.1 Global Live Attenuated Vaccine Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Medical Center
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Live Attenuated Vaccine Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Live Attenuated Vaccine Industry
- 1.6.1.1 Live Attenuated Vaccine Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Live Attenuated Vaccine Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Live Attenuated Vaccine Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Live Attenuated Vaccine Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Live Attenuated Vaccine Market Size Estimates and Forecasts
- 2.1.1 Global Live Attenuated Vaccine Revenue 2015-2026
- 2.1.2 Global Live Attenuated Vaccine Sales 2015-2026
- 2.2 Live Attenuated Vaccine Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Live Attenuated Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Live Attenuated Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Live Attenuated Vaccine Competitor Landscape by Players
- 3.1 Live Attenuated Vaccine Sales by Manufacturers
- 3.1.1 Live Attenuated Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Live Attenuated Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Live Attenuated Vaccine Revenue by Manufacturers
- 3.2.1 Live Attenuated Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Live Attenuated Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Live Attenuated Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Live Attenuated Vaccine Revenue in 2019
- 3.2.5 Global Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Live Attenuated Vaccine Price by Manufacturers
- 3.4 Live Attenuated Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Live Attenuated Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Live Attenuated Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Live Attenuated Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Live Attenuated Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Live Attenuated Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Live Attenuated Vaccine Revenue by Type (2015-2020)
- 4.1.3 Live Attenuated Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Live Attenuated Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Live Attenuated Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Live Attenuated Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Live Attenuated Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Live Attenuated Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Live Attenuated Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Live Attenuated Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Live Attenuated Vaccine Revenue by Application (2015-2020)
- 5.1.3 Live Attenuated Vaccine Price by Application (2015-2020)
- 5.2 Live Attenuated Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Live Attenuated Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Live Attenuated Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Live Attenuated Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Live Attenuated Vaccine by Country
- 6.1.1 North America Live Attenuated Vaccine Sales by Country
- 6.1.2 North America Live Attenuated Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Live Attenuated Vaccine Market Facts & Figures by Type
- 6.3 North America Live Attenuated Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Live Attenuated Vaccine by Country
- 7.1.1 Europe Live Attenuated Vaccine Sales by Country
- 7.1.2 Europe Live Attenuated Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Live Attenuated Vaccine Market Facts & Figures by Type
- 7.3 Europe Live Attenuated Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Live Attenuated Vaccine by Region
- 8.1.1 Asia Pacific Live Attenuated Vaccine Sales by Region
- 8.1.2 Asia Pacific Live Attenuated Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Live Attenuated Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Live Attenuated Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Live Attenuated Vaccine by Country
- 9.1.1 Latin America Live Attenuated Vaccine Sales by Country
- 9.1.2 Latin America Live Attenuated Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Live Attenuated Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Live Attenuated Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Live Attenuated Vaccine by Country
- 10.1.1 Middle East and Africa Live Attenuated Vaccine Sales by Country
- 10.1.2 Middle East and Africa Live Attenuated Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Live Attenuated Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Live Attenuated Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Astellas Pharma (Japan)
- 11.1.1 Astellas Pharma (Japan) Corporation Information
- 11.1.2 Astellas Pharma (Japan) Description, Business Overview and Total Revenue
- 11.1.3 Astellas Pharma (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Products Offered
- 11.1.5 Astellas Pharma (Japan) Recent Development
- 11.2 CSL Limited (Australia)
- 11.2.1 CSL Limited (Australia) Corporation Information
- 11.2.2 CSL Limited (Australia) Description, Business Overview and Total Revenue
- 11.2.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 CSL Limited (Australia) Live Attenuated Vaccine Products Offered
- 11.2.5 CSL Limited (Australia) Recent Development
- 11.3 Emergent BioSolutions (U.S.)
- 11.3.1 Emergent BioSolutions (U.S.) Corporation Information
- 11.3.2 Emergent BioSolutions (U.S.) Description, Business Overview and Total Revenue
- 11.3.3 Emergent BioSolutions (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Products Offered
- 11.3.5 Emergent BioSolutions (U.S.) Recent Development
- 11.4 GlaxoSmithKline (U.K.)
- 11.4.1 GlaxoSmithKline (U.K.) Corporation Information
- 11.4.2 GlaxoSmithKline (U.K.) Description, Business Overview and Total Revenue
- 11.4.3 GlaxoSmithKline (U.K.) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Products Offered
- 11.4.5 GlaxoSmithKline (U.K.) Recent Development
- 11.5 Johnson & Johnson (U.S.)
- 11.5.1 Johnson & Johnson (U.S.) Corporation Information
- 11.5.2 Johnson & Johnson (U.S.) Description, Business Overview and Total Revenue
- 11.5.3 Johnson & Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Johnson & Johnson (U.S.) Live Attenuated Vaccine Products Offered
- 11.5.5 Johnson & Johnson (U.S.) Recent Development
- 11.6 MedImmune (U.S.)
- 11.6.1 MedImmune (U.S.) Corporation Information
- 11.6.2 MedImmune (U.S.) Description, Business Overview and Total Revenue
- 11.6.3 MedImmune (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 MedImmune (U.S.) Live Attenuated Vaccine Products Offered
- 11.6.5 MedImmune (U.S.) Recent Development
- 11.7 Merck & Co (U.S.)
- 11.7.1 Merck & Co (U.S.) Corporation Information
- 11.7.2 Merck & Co (U.S.) Description, Business Overview and Total Revenue
- 11.7.3 Merck & Co (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Merck & Co (U.S.) Live Attenuated Vaccine Products Offered
- 11.7.5 Merck & Co (U.S.) Recent Development
- 11.8 Pfizer (U.S.)
- 11.8.1 Pfizer (U.S.) Corporation Information
- 11.8.2 Pfizer (U.S.) Description, Business Overview and Total Revenue
- 11.8.3 Pfizer (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Pfizer (U.S.) Live Attenuated Vaccine Products Offered
- 11.8.5 Pfizer (U.S.) Recent Development
- 11.9 Sanofi Pasteur (France)
- 11.9.1 Sanofi Pasteur (France) Corporation Information
- 11.9.2 Sanofi Pasteur (France) Description, Business Overview and Total Revenue
- 11.9.3 Sanofi Pasteur (France) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Sanofi Pasteur (France) Live Attenuated Vaccine Products Offered
- 11.9.5 Sanofi Pasteur (France) Recent Development
- 11.10 Serum Institute of India Pvt (India)
- 11.10.1 Serum Institute of India Pvt (India) Corporation Information
- 11.10.2 Serum Institute of India Pvt (India) Description, Business Overview and Total Revenue
- 11.10.3 Serum Institute of India Pvt (India) Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Serum Institute of India Pvt (India) Live Attenuated Vaccine Products Offered
- 11.10.5 Serum Institute of India Pvt (India) Recent Development
- 11.1 Astellas Pharma (Japan)
- 11.1.1 Astellas Pharma (Japan) Corporation Information
- 11.1.2 Astellas Pharma (Japan) Description, Business Overview and Total Revenue
- 11.1.3 Astellas Pharma (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Astellas Pharma (Japan) Live Attenuated Vaccine Products Offered
- 11.1.5 Astellas Pharma (Japan) Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Live Attenuated Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Live Attenuated Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Live Attenuated Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Live Attenuated Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Live Attenuated Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Live Attenuated Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Live Attenuated Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Live Attenuated Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Live Attenuated Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Live Attenuated Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Live Attenuated Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Live Attenuated Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Live Attenuated Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Live Attenuated Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Live Attenuated Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Live Attenuated Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Live Attenuated Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Live Attenuated Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Live Attenuated Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Live Attenuated Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Live Attenuated Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Live Attenuated Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Live Attenuated Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Live Attenuated Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Live Attenuated Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Live Attenuated Vaccine. Industry analysis & Market Report on COVID-19 Impact on Global Live Attenuated Vaccine is a syndicated market report, published as COVID-19 Impact on Global Live Attenuated Vaccine, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Live Attenuated Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
